| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. (VIR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. VIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.73M | $139.62M | - | |
| Dir | 1.10M | $11.19M | - | |
| CEO | 714.6K | $7.27M | - | |
| CFO | 160.1K | $1.63M | - | |
| VP | 104.6K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,375 | $36.94 | $50,792.50 | -1.3% | -6.6% | -39.3% | |
| Oct 20, 2021 | Pang Phillip80 | Chief Medical Officer | Sell | 4,000 | $39.65 | $158,596.00 | -3.8% | -10.0% | -48.7% | |
| Oct 19, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,375 | $38.87 | $53,446.25 | -1.3% | -11.3% | -49.1% | |
| Oct 19, 2021 | Sato Vicki L73 | Director | Sell | 15,174 | $39.56 | $600,313.80 | -0.5% | -11.3% | -49.1% | |
| Oct 6, 2021 | Pang Phillip80 | Chief Medical Officer | Sell | 5,000 | $34.56 | $172,780.50 | -4.6% | +10.7% | -36.4% | |
| Oct 5, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,375 | $33.75 | $46,406.25 | -1.3% | +11.6% | -37.0% | |
| Sep 21, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 4,125 | $50.00 | $206,250.00 | -4.0% | +0.3% | -63.3% | |
| Sep 17, 2021 | Sato Vicki L73 | Director | Sell | 15,174 | $52.48 | $796,301.19 | -0.5% | -0.9% | -63.3% | |
| Sep 15, 2021 | Pang Phillip80 | Chief Medical Officer | Sell | 5,000 | $49.69 | $248,461.60 | -2.3% | -12.0% | -61.2% | |
| Sep 7, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 4,125 | $49.67 | $204,875.00 | -2.0% | -22.7% | -55.7% |